Christopher Simms

Insider Reports History

Entity
Individual
Location
Five Penn Plaza Suite 2372, New York, NY
Signature
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Christopher Simms
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Simms:

Stock Role Class Num Shares Value Price $ Report Date Ownership
IVERIC bio, Inc. SVP, Chief Commercial Officer Common Stock 0 $39.45 Jul 11, 2023 Direct
IVERIC bio, Inc. SVP, Chief Commercial Officer Restricted Stock Units 0 Jul 11, 2023 Direct
IVERIC bio, Inc. SVP, Chief Commercial Officer Stock Option (Right to Buy) 0 $10.03 Jul 11, 2023 Direct

Insider Reports Filed by Christopher Simms

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ISEE IVERIC bio, Inc. Jul 11, 2023 7 $0 4 Jul 13, 2023 SVP, Chief Commercial Officer
ISEE IVERIC bio, Inc. Jan 2, 2023 3 -$47.5K 4 Jan 4, 2023 SVP, Chief Commercial Officer
ISEE IVERIC bio, Inc. Dec 20, 2022 2 $0 4 Dec 22, 2022 SVP, Chief Commercial Officer
ISEE IVERIC bio, Inc. Aug 2, 2022 6 -$138K 4 Aug 4, 2022 SVP, Chief Commercial Officer
ISEE IVERIC bio, Inc. Dec 16, 2021 2 $0 4 Dec 20, 2021 SVP, Chief Commercial Officer
ISEE IVERIC bio, Inc. Nov 18, 2021 1 $50K 4 Nov 22, 2021 SVP, Chief Commercial Officer
(ISEE) IVERIC bio, Inc. Aug 2, 2021 3 $0 4 Aug 4, 2021 Senior Vice President, CCO
ISEE IVERIC bio, Inc. Aug 2, 2021 0 $0 3 Aug 4, 2021 Senior Vice President, CCO